home / stock / mmirf / mmirf quote
Last: | $0.06 |
---|---|
Change Percent: | 0.0% |
Open: | $0.06 |
Close: | $0.06 |
High: | $0.06 |
Low: | $0.06 |
Volume: | 4,000 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 4,000 | 05-03-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 35,000 | 05-02-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 11,000 | 05-01-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 6,000 | 04-16-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 50,000 | 04-12-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 10,000 | 04-11-2024 |
$0.0616 | $0 | $0.0616 | $0 | $0 | 70 | 03-25-2024 |
$0.0616 | $0 | $0.0616 | $0 | $0 | 20 | 02-26-2024 |
$0.0616 | $0.0616 | $0.0616 | $0.0616 | $0.0616 | 2,000 | 02-05-2024 |
$0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 1,000 | 02-01-2024 |
$0.035 | $0.035 | $0.035 | $0.035 | $0.035 | 3,000 | 01-10-2024 |
$0.2 | $0.2 | $0.2 | $0.2 | $0.2 | 550 | 01-09-2024 |
$0.013 | $0.013 | $0.013 | $0.013 | $0.013 | 2,000 | 01-04-2024 |
$0.0738 | $0.0738 | $0.0738 | $0.0738 | $0.0738 | 2,000 | 01-02-2024 |
$0.0669 | $0.0669 | $0.0669 | $0.0669 | $0.0669 | 1,748 | 12-28-2023 |
$0.0746 | $0.0746 | $0.0746 | $0.0746 | $0.0746 | 2,000 | 12-27-2023 |
$0.043 | $0.043 | $0.043 | $0.043 | $0.043 | 2,000 | 12-26-2023 |
$0.023 | $0 | $0.023 | $0 | $0 | 1 | 12-18-2023 |
$0.023 | $0.023 | $0.023 | $0.023 | $0.023 | 450 | 12-05-2023 |
$0.042 | $0 | $0.042 | $0 | $0 | 60 | 12-04-2023 |
News, Short Squeeze, Breakout and More Instantly...
HALIFAX, NS / ACCESSWIRE / April 30, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the position of Vice President of Business Development. Ms. Bell brings over 20 years of Business Development a...
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this...